ArticleCPT: pharmacometrics & systems pharmacology2020

Multiscale Model Identifies Improved Schedule for Treatment of Acute Myeloid Leukemia In Vitro With the Mcl-1 Inhibitor AZD5991.

Ardeshir Goliaei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.